Photo via ProPublica

Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In

Read the original at ProPublica ↗
Cite

Roberts, B. (2026, October 29). Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In. ProPublica. https://www.propublica.org/article/hhs-alicia-jackson-menopause-treatment-policy

Dated from the outlet's own feed. Check the original for its byline.

ProPublica · collected 2026-10-29 · by Brandon Roberts

Quick Summary

Alicia Jackson, director of ARPA-H, praised the removal of “black box” warnings on hormone replacement therapies during an HHS press conference in November, calling it a victory for women's health. However, ProPublica reports that Jackson retained $115,000 worth of stock and unspecified options in Evernow, an online platform she founded that connects women with menopause experts, raising concerns about potential conflicts of interest. Ethics experts criticized her endorsement as a government official while holding financial stakes in a company set to benefit from the policy change.
Written by AI on 2026-10-31, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

As of October 29, 2026, Alicia Jackson, the director of a federal health agency within HHS that invests taxpayer money in medical technology and research, praised a policy shift eliminating "black box" warnings on hormone replacement therapies for menopause. At a press conference, Jackson endorsed the decision, stating it was a victory for women's health and science, but ProPublica revealed she retained stock worth at least $115,000 in Evernow, an online platform connecting women with medical experts for menopause treatment. This disclosure raises concerns about potential conflicts of interest given Jackson’s involvement in advancing the policy that benefits her former company. HHS maintains there was no wrongdoing, citing adherence to federal ethics laws and regulations, but ProPublica's investigation questions the integrity of such claims due to financial ties.

Written for “Fda Official's Conflict Of Interest” on 2026-11-01, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Fda Official's Conflict Of Interest
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 14% of its claims. Each row says how that neighbour differs.
The Bulwark
⚖️ Leans left Hedges 0 of 8 claims
“The articles describe different events: one is an interview with Mark Cuban criticizing healthcare giants, while the other reports on a health official supporting a policy change.”
The Guardian
Hedges 3 of 26 claims Outlet record 66/100
“The articles describe related decisions but not the same specific press conference or announcement. Article A refers to a November announcement by HHS while Article B mentions an October press briefing from FDA.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
102
sentences that state something as happening or true
Uncertain
14%
14 of 102 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
58/100
ProPublica's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-31 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

ProPublica · 121 article(s) · 1 correction(s) detected
Running correction rate · 1 correction(s)

Who wrote this

Brandon Roberts
2 article(s) here · 1 carrying a prediction
🔮 Less clear that day were the financial benefits the new policy could bring Jackson, according to disclosure records obtained by ProPublica.
🔮 Our team may not be able to respond to everyone personally, but we will read everything you submit.
Also by Brandon Roberts
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Evernow HHS ProPublica the Advanced Research Projects Agency for Health the Department of Health and Human Services

Subjects

Jackson GPE · 14× HHS ORG · 5× Evernow ORG · 3× ProPublica ORG · 3× ARPA-H. ORG · 1× Alicia Jackson PERSON · 1× Virginia Canter PERSON · 1× the Advanced Research Projects Agency for Health ORG · 1× the Department of Health and Human Services ORG · 1× the Food and Drug Administration ORG · 1×

Narrative

HHS denied any wrongdoing by Kennedy, telling the Times the secretary “complies with all applicable federal ethics laws, regulations and financial disclosure requirements.” Campaign Legal Center’s analysis of federal ethics staff this year found Kennedy’s cuts to the agency eliminated nearly 30% of HHS’ full-time ethics workers. Another HHS official whose disclosures raised ethical alarms was the agency’s top attorney, Mike Stuart.
framing: assertive · carried by 1 article(s) · first seen 2026-10-31
🔮 Less clear that day were the financial benefits the new policy could bring Jackson, according to disclosure records obtained by ProPublica.

Claims (102 extracted, 14 hedged)

Last November, the Department of Health and Human Services announced the elimination of “black box” warnings on hormone replacement therapies, aiming to reverse nearly two decades of stigma surrounding a key treatment for menopause symptoms. asserted
Department → announce → symptoms
Among the officials at a press conference about the decision was Alicia Jackson, director of a federal health agency that invests taxpayer money in medical technology and research. asserted
that → invest → technology
As Jackson stood behind a lectern adorned with the HHS logo, she praised the new policy, calling it a victory for women and science. asserted
she → stand → women
“Today we have the opportunity to add up to a decade of healthy years to the life of every woman that you love,” Jackson said. asserted
Jackson → have → that
Less clear that day were the financial benefits the new policy could bring Jackson, according to disclosure records obtained by ProPublica. uncertain
policy → bring → ProPublica
Jackson is the founder and former chief executive of Evernow, an online platform that connects women with medical experts who treat the symptoms of menopause. asserted
who → connect → menopause
Although she left for federal service last year, she kept at least $115,000 in Evernow stock and an unknown amount of stock options, records show. asserted
records → leave → options
Those are just part of a multimillion-dollar portfolio Jackson holds with her husband, a venture capitalist, that poses potential conflicts of interest with her work overseeing the Advanced Research Projects Agency for Health, known as ARPA-H. It’s unclear what role, if any, Jackson played in dropping the black box warning, the most serious type of federal safety warning that is reserved for drugs with severe side effects or life-threatening risks. uncertain
that → hold → effects
A different agency, the Food and Drug Administration, regulates drugs, and its panel of experts had recommended an end to the warning requirement months before Jackson arrived in government. asserted
Jackson → regulate → government
But ethics experts called Jackson’s official endorsement of the warning removal “alarming” and an “obvious conflict of interest,” noting federal law prohibits government employees from participating “personally and substantially” in matters that could influence their personal finances — even making statements at a press conference or in a news release, as she also did. “We should care because her company is apparently intending to profit off this change in policy that she endorsed as a government official while still retaining a financial interest in the company,” said Virginia Canter, who served as an ethics lawyer at the White House, Treasury Department and Securities and Exchange Commission during the presidencies of George H.W. Bush, Bill Clinton, George W. Bush and Barack Obama. uncertain
who → call → Bush
“I say it puts her within the zone of a potential violation,” she said. asserted
she → say → violation
Months after the announced end to the warning notices, Evernow launched a nationwide expansion. asserted
Evernow → announce → expansion
Under federal law, agency officials like Jackson are required to submit financial disclosure forms, which must then be certified as complying with ethics laws. asserted
which → require → laws
But Jackson’s two financial disclosures — filed last October and two months ago — remain uncertified. asserted
disclosures → file → ?
Canter said it is not unusual for an agency’s ethics office to ask the inspector general to investigate if staff cannot certify that an individual’s disclosure forms meet ethics standards. asserted
forms → say → standards
Over two months, ProPublica sought comment from Jackson and submitted questions about her work, investments and ethics records. asserted
ProPublica → seek → work
Jackson did not respond, and HHS never addressed our detailed questions. asserted
HHS → respond → questions
But in a statement to ProPublica last week, an agency spokesperson said Jackson has been placed on administrative leave and HHS would “assess the facts before determining any change in her status. asserted
HHS → say → status
HHS requires all officials to comply with federal ethics laws, regulations, and policies.” asserted
HHS → require → laws
HHS declined to answer additional questions about the reasons for Jackson’s leave, the decision’s timing or whether the inspector general was investigating. asserted
general → decline → leave
Earlier this week, Bloomberg Law reported on the HHS statement that Jackson was on leave and made public a draft memo by one of the agency’s senior officials that would have granted Jackson a conflict waiver involving many of her and her husband’s extensive investments. asserted
that → report → investments
Since she joined ARPA-H, the memo said, Jackson and her husband’s financial ties required her to recuse herself from “a significant portion” of her duties, including discussions about funding awarded by her agency. asserted
Jackson → join → agency
The waiver named 30 investments and would have allowed Jackson to take part in decisions that could affect those interests. uncertain
that → name → interests
Evernow is not listed. asserted
Evernow → list → ?
Bloomberg reported that two firms with ties to Jackson sought ARPA-H funding, but it was unclear if either received any. uncertain
either → report → any
HHS did not respond to ProPublica’s questions asking whether the waiver was ever granted or if the firms had received money from ARPA-H. asserted
firms → respond → money
The Office of Government Ethics does not list Jackson among federal officials who have received waivers. asserted
who → list → waivers
Jackson’s disclosures are among 2,400 added Thursday to ProPublica’s Trump Team Financials database, a searchable tool launched in March. asserted
disclosures → add → March
The records detail the finances of more than 2,300 officials appointed by President Donald Trump. asserted
records → detail → Trump
Since last year, we’ve requested disclosure records from 127 federal agencies and the White House. asserted
we → request → agencies
Disclosures from roughly 1,500 appointees remain unreleased. asserted
Disclosures → remain → appointees
The Trump administration’s massive cuts to the federal bureaucracy have taken a toll on the ranks of ethics staff. asserted
cuts → take → staff
Some agencies said the losses hampered ethics officers’ ability to conduct training and monitor employee compliance. asserted
losses → say → compliance
Trump appointees failed to file nearly 420 legally mandated public financial disclosure reports last year, almost a fourfold spike compared with the Biden administration’s last full year, the center found. asserted
center → fail → year
Nevertheless, our database provides the most complete source yet for this administration’s ethics documents. asserted
database → provide → documents
Jackson spent years navigating the worlds of technological research, government and entrepreneurship, according to her government bio and LinkedIn profile. uncertain
Jackson → spend → bio
After earning a doctorate in materials science from the Massachusetts Institute of Technology in 2007, she worked briefly as a U.S. Senate policy staffer. asserted
she → earn → staffer
She subsequently joined the Pentagon’s Defense Advanced Research Projects Agency as a program manager, later becoming deputy director of its first biotechnology office. asserted
She → join → office
Jackson left the Defense Department in mid-2015, going on to lead several biotech businesses before starting Evernow in 2019. asserted
Jackson → leave → 2019
The San Francisco-based company connects women experiencing sometimes debilitating menopause symptoms with medical providers who prescribe treatments. asserted
who → base → treatments
…and 62 more, not listed.
💬Give feedback
🕘History 🎫Support